Arbor Biotechnologies, Inc. — Form D/A
Arbor Biotechnologies, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2017-08-02. The offering totals $15.6M, of which $15.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-02
- Form: D/A
- Accession: 0001707499-17-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.6M
- Amount sold: $15.6M
- Investors: 10
- Date of first sale: 2017-05-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-287829
Issuer
- Name: Arbor Biotechnologies, Inc.
- CIK: 0001707499
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 20 ACORN PARK DRIVE, CAMBRIDGE, MA, 02140
- Phone: 860-287-7984
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| KEITH XIA CRANDELL | Director | CAMBRIDGE, MA |
| ANNIE XIA HAZLEHURST | Director | CAMBRIDGE, MA |
| David R Walt | Director | Billerica, MA |
| FENG R ZHANG | Director | CAMBRIDGE, MA |
| DAVID ARTHUR SCOTT | Executive Officer | CAMBRIDGE, MA |
| WINSTON XIA YAN | Executive Officer | CAMBRIDGE, MA |
| Paul Meister | Director | Waltham, MA |
| David Walt | Director | Cambridge, MA |
| Keith Crandell | Director | Sunnyvale, CA |
| Kelly Morgan | Executive Officer | Las Vegas, NV |
| John Murphy | Executive Officer | Beaver Falls, PA |
| CHEN YU | Director | PALO ALTO, CA |
| DAVID CHENG | Executive Officer | Hayward, CA |
| RAMI HARAWI | Director | CAMBRIDGE, MA |
| MARK ANGELINO | Director | CAMBRIDGE, MA |
| PAM STETKIEWICZ | Executive Officer | CAMBRIDGE, MA |
| DEVYN SMITH | Director | CAMBRIDGE, MA |
| DEVYN SMITH | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (2)
More